Oral Abstract Session:
112. Innate and Adaptive Immunity to Infections
Saturday, October 22, 2011: 8:15 AM-9:45 AM
Room: 156ABC

Learning Objectives:

none

Target Audience: Academicians, other

Topical Category: E. Innate and adaptive immunity to infections, including vaccine immunology

Tracks: Investigative ID, Pediatric ID, Adult ID

Moderators:  Anne Kasmar, MD MSc, Harvard Medical School and Michael Glickman, MD, Memorial Sloan Kettering Cancer Center

Presentations:

8:45 AM
838
Lifelong persistence of circulating human B cells specifying monoclonal antibodies to pandemic 1957 H2N2 influenza virus that target the receptor-binding domain
Jens C. Krause, M.D. ; Tshidi Tsibane, Ph.D. ; Chelsey J. Huffman ; David Blum, Ph.D. ; Kathryn Edwards, MD, FIDSA ; Christopher F. Basler, Ph.D. ; James E. Crowe Jr., MD, FIDSA

9:00 AM
839
Children with Invasive Staphylococcal Disease Exhibit a Potent Neutralizing Antibody Response to the Newly Described Cytotoxin, LukAB/LukGH
Isaac Thomsen, MD ; Elizabeth Saye, B.S. ; Victor Torres, Ph.D. ; C. Buddy Creech, MD, MPH

9:15 AM
840
Clinical characteristics and serologic biomarkers associated with TB relapse and death in HIV/TB co-infected persons
Matifadza Hlatshwayo ; Christopher Whalen, MD, MS ; Robert Kalayjian, MD ; Charles Mahan, MD

9:30 AM
841
Peripheral mechanisms of CD4 T cell regeneration in HIV-1 elite controllers
Yue Yang, MD ; Jill Beamon ; Katherine Seiss ; Ildiko Toth ; Eric Rosenberg, MD ; Florencia Pereyra, MD ; Xu Yu, MD ; Mathias Lichterfeld, MD, PhD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

A. Kasmar, None

M. Glickman, None

M. Glickman, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.